BioSpace News Archive

Genetown

eClinical Solutions’ Thought Leaders to Discuss the Future of Data Standards, Risk-Based Approaches, and Digital Trials at PHUSE EU Connect 2022, Medidata NEXT New York 2022 and More

Presentations and demonstrations will highlight how modern clinical data infrastructure and analytics platforms and optimized processes accelerate increasingly complex trials.

November 10, 2022
·
5 min read
Hearing Loss Disease Treatment Market Size, Share, Growth, Trends | Report 2022-2030

Hearing loss has a serious impact on an individual’s growth and development. According to WHO, globally 430 million people or approximately 5% of the world’s population require attention and action for their hearing disability.

November 10, 2022
·
4 min read
Business

Sientra Reports Record Third Quarter 2022 Financial Results

Sientra, Inc., a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, announced its financial results for the third quarter that ended September 30, 2022.

November 10, 2022
·
17 min read
Business

Viracta Therapeutics Reports Third Quarter 2022 Financial Results and Provides Updates on Clinical Programs

Viracta Therapeutics, Inc. reported financial results for the third quarter of 2022 and provided an update on recent corporate developments.

November 10, 2022
·
15 min read
Business

Venus Concept Announces Third Quarter of Fiscal Year 2022 Financial Results

Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and nine months ended September 30, 2022.

November 10, 2022
·
18 min read
Biotech Bay

Akero Therapeutics to Present at Upcoming Healthcare Conferences in November 2022

Akero Therapeutics, Inc. announced that management will present at the following investor conferences this month:

November 10, 2022
·
2 min read
Business

89bio Reports Third Quarter 2022 Financial Results and Provides Corporate Update

89bio, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, reported its financial results for the third quarter ended September 30, 2022.

November 10, 2022
·
8 min read
Business

Oyster Point Pharma Reports Third Quarter 2022 Financial Results and Recent Business Highlights

Oyster Point Pharma, Inc. announced its financial results for the quarter ended September 30, 2022, and provided an overview of recent business highlights.

November 10, 2022
·
20 min read
Business

Journey Medical Corporation Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights

Journey Medical Corporation announced financial results and recent corporate highlights for the third quarter and nine months ended September 30, 2022.

November 10, 2022
·
15 min read
BiondVax Announces Plan to Implement ADS Ratio Change

BiondVax Pharmaceuticals Ltd. announces that it plans to effect a ratio change of the Company’s American Depositary Shares to its non-traded ordinary shares from the current ratio of one ADS representing forty ordinary shares to a new ratio of one ADS representing four hundred ordinary shares.

November 10, 2022
·
4 min read